Researchers are developing genomic screening tools to tailor radiation dose and hormone therapy for prostate cancer patients, ...
Investigators developed and validated new PSMA-PET-based nomograms for prognostication across prostate cancer stages to help ...
The 2026 PSMA & Beyond conference featured a targeting the cell surface session and presentation by Dr. Rahul Aggarwal discussing DLL3 and whether target expression determines the method of targeting.
Most prostate cancers are initially diagnosed as localized disease and can be effectively treated with surgery or radiation therapy. However, a subset of ...
The 2026 PSMA & Beyond conference featured a clinical development session and presentation by Dr. William Maguire discussing regulatory considerations related to PSMA PET imaging in clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results